- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Solitary metastatic adenocarcinoma of the sternum treated by total sternectomy and chest wall reconstruction using a Gore-Tex patch and myocutaneous flap: a case report
© Daliakopoulos et al; licensee BioMed Central Ltd. 2010
Received: 21 September 2008
Accepted: 1 March 2010
Published: 1 March 2010
The consequences of bone metastasis are often devastating. Although the exact incidence of bone metastasis is unknown, it is estimated that 350,000 people die of bone metastasis annually in the United States. The incidence of local recurrences after mastectomy and breast-conserving therapy varies between 5% and 40% depending on the risk factors and primary therapy utilized. So far, a standard therapy of local recurrence has not been defined, while indications of resection and reconstruction considerations have been infrequently described. This case report reviews the use of sternectomy for breast cancer recurrence, highlights the need for thorough clinical and radiologic evaluation to ensure the absence of other systemic diseases, and suggests the use of serratus anterior muscle flap as a pedicle graft to cover full-thickness defects of the anterior chest wall.
We report the case of a 70-year-old Caucasian woman who was referred to our hospital for the management of a retrosternal mediastinal mass. She had undergone radical mastectomy in 1999. Computed tomography and magnetic resonance imaging revealed a 74.23 × 37.7 × 133.6-mm mass in the anterior mediastinum adjacent to the main pulmonary artery, the right ventricle and the ascending aorta. We performed total sternectomy at all layers encompassing the skin, the subcutaneous tissues, the right pectoralis major muscle, all the costal cartilages, and the anterior part of the pericardium. The defect was immediately closed using a 0.6 mm Gore-Tex cardiovascular patch combined with a serratus anterior muscle flap. Our patient had remained asymptomatic during her follow-up examination after 18 months.
Chest wall resection has become a critical component of the thoracic surgeon's armamentarium. It may be performed to treat either benign conditions (osteoradionecrosis, osteomyelitis) or malignant diseases. There are, however, very few reports on the results of full-thickness complete chest wall resections for locally recurrent breast cancer with sufficient safety margins, and even fewer reports that describe the operative technique of using the serratus anterior muscle as a pedicled flap.
Bone metastasis is a frequent complication of cancer. It occurs in up to 70% of patients with advanced breast or prostate cancer and in approximately 15% to 30% of patients with carcinoma of the lung, colon, stomach, bladder uterus, rectum, thyroid or kidney. Breast cancer has the tendency to relapse in the bones, and 56% of autopsy cases reveal the occurrence of bone metastasis. The most frequent sites of bone metastasis are the thoracic and lumbosacral spine. The consequences of bone metastasis are often devastating, as only 20% of patients with breast cancer are still alive five years after the discovery of bone metastasis. Chest wall resection for breast cancer was first performed by Schede in 1866 and then by Sauerbruch in 1907. Meanwhile, partial sternectomy for a primary sarcoma was first described by Holden in 1878. In 1959, Brodin and Linden first performed and described total sternectomy due to chondrosarcoma involving the entire sternum.
The surgical treatment of chest wall tumors challenges the aggressiveness and ingenuity of the operating surgeon who closes the defect. Partial or total sternectomy, together with rib resection, are common thoracic surgical procedures. These are undertaken for primary and secondary tumors arising from any of the structures forming the chest wall, as well as recurrent breast cancer or lung tumors invading the chest wall. Myocutaneous flaps and prosthetic materials greatly facilitate reconstruction after massive chest wall resection.
We report the case of a 70-year old Caucasian woman who was referred to the thoracic oncology unit of our hospital for the management of a retrosternal mediastinal mass. She had been well 8 weeks before admission when she experienced the sudden onset of sharp left anterior chest pain. The pain was worse in the area adjacent to the sternum and also worsens when she takes a deep breath. In 1999, she underwent radical left side mastectomy followed by CEF (cyclophosphamide, epirubin and fluorouracil) chemotherapy and radiotherapy. The clinical and histological characteristics of the primary breast cancer revealed a Stage IIIa adenocarcinoma with positive axillary lymph node metastasis. Her estrogen receptor assay, as well as the amplification of the human epidermal growth factor receptor type 2 (HER 2/neu) was negative. Expression of her progesterone receptors was defined as low (Reiner score for staining of tumour-cell nuclei). On admission our patient's vital signs were normal. She had neither jugular venous distension nor cervical or supraclavicular lymphadenopathy. Her chest was clear on auscultation. There was no tenderness on palpation of her ribs or sternum. The remainder of her examination results was normal.
Our patient was anaesthetized and ventilated with a double-lumen endotracheal tube. An epidural catheter was also inserted for pain control during the peri-operative period. Our patient was placed at first in a right thoracotomy position with soft rotation of the coxa towards the surgeon. Standard thoracotomy incision was used to expose the serratus anterior muscle (SAM). The SAM was identified and mobilized by separating it from the chest wall and then carefully dividing its attachments to the first 4 to 5 ribs, with a periosteal elevator at first and then with a cautery. As dissection proceeded upward toward her axilla, the contribution of the lateral thoracic artery was seen entering the muscle on its anterior cephalic border. The blood supply to the serratus anterior may come from the thoracodorsal pedicle, from the subscapular pedicle, or directly from the axillary artery. In our case, our patient's blood supply came from the serratus anterior branch from the thoracodorsal artery, which originates as the largest branch from the subscapular artery. During the procedure these branches were identified and preserved. The harvested SAM was advanced and transposed within its arc of rotation towards the midsternal line to cover the defect.
Epidural analgesia was employed in the immediate postoperative period. Postoperative respiratory function tests revealed satisfactory results and our patient could be relieved from endotracheal intubation a day after the operation. She did not have any problems in her daily activities or any occurrence of chest flailing or paradoxical movement of the chest. Scapular winging occurred although any effort was made to preserve the a third of the lower part of her serratus anterior muscle. No flap infection or wound dehiscence was noted, and she was discharged from the hospital nine days after the operation.
She received two additional cycles of CEF chemotherapy consisting of 2 cycles of oral cyclophosphamide at a dose of 75 mg/m2 on days 1 through 14, 60 mg/m2 of epirubicin on days 1 and 8, and 500 mg/m2 of fluorouracil intravenously on days 1 and 8. During her CEF therapy she also received antibiotic prophylaxis with ciprofloxacin at a dose of 500 mg orally twice daily. She is well 18 months after the diagnosis, and she exhibited no evidence of recurrent disease on serial CT and MRI scans of her chest, abdomen, and brain. She remains asymptomatic and the stability of her chest wall is well-preserved.
The operative management of massive chest wall malignancies presents as an infrequent but formidable surgical challenge mainly because of the difficulty in making full thickness resections without compromising the stability and the reconstruction of the chest wall. A review of the literature showed that a complete chest wall resection is only performed in very rare cases, with the largest reported study in the last 20 years coming from Mora et al. and including 69 patients . In patients with breast cancer, the presence of either sternal involvement or an isolated sternal metastasis is relatively uncommon, with reported incidences of 5.2% and 1.9% to 2.4%, respectively . Sternal involvement may occur either from direct invasion by enlarged internal mammary lymph nodes or from hematogenous spread. However, in contrast with vertebra lesions, which tend to result in multicentric bony disease from spread through the paravertebral plexus , some sternal lesions have been observed to remain solitary over time and may be amenable to surgical resection with curative intent . Although local recurrence after breast surgery does not consistently represent systemic metastasis , the role of surgery is controversial in breast cancer metastasis involving the thoracic wall and the sternum , as well as in sternectomy for isolated breast cancer. This can be gleaned from the fact that the literature consists predominantly of retrospective case series.
Meanwhile, local recurrence following the primary treatment of breast cancer ranges from less than 5% for stage I to greater than 25% for stages II and III with an extremely variable disease-free interval . Since chest wall recurrence is associated with disseminated metastasis in 60% to 100% of cases, simple excision, radiation therapy and chemotherapy are utilized to treat local and systemic diseases. Noguti et al. performed sternal resections with parasternal and mediastinal lymph node dissection on nine patients before chemo-endocrine therapy was undertaken. The eventual relapse of the cancer in 8 patients revealed that lymph node dissection had no effect on locoregional control. Nevertheless, dissection provided prognostic information because all patients with involved parasternal and mediastinal lymph nodes relapsed and died within 30 months, while 3 patients without lymph node involvement survived for more than 6 years.
Lequaglie et al. performed radical, curative-intent sternectomies in a subgroup of 28 patients with isolated breast cancer recurrence and noted that the 10-year overall survival in the group was 41.8% . Meanwhile, McCormack et al. noted in a series of 35 patients that 20 (57.14%) were alive from 5 to 120 months with a median of 50 months . These authors stated that surgical resection of recurrent mammary carcinoma resistant to all other therapy is a viable alternative for palliation and cure in patients who were carefully selected.
Furthermore, Avital et al. presented two patients with isolated sternal metastasis from breast cancer that underwent sternectomy followed by systemic chemotherapy and irradiation. Follow-up examinations continued for 30 and 36 months and they were alive and living a good quality of life during this period. One of them, however, had local recurrence in the axilla, but this was resected successfully. Meanwhile, in a series of 100 patients, Brower et al. observed that the incidence of local recurrence after radical chest wall resection was 20%, while the incidence of systemic recurrence after chest wall resection was 60%. The mean survival for the entire group was 17 months after chest wall recurrence and radical resection.
On the other hand, Kwai et al. stated that an isolated sternal metastasis should be regarded with caution because it is more likely to herald systemic disease than to develop as solitary sternal disease . The authors demonstrated that 54% of patients with breast cancer and solitary sternal disease developed other foci of distant disease within 20 months. The predominance of pulmonary metastasis and distant skeletal disease found in their study was attributed to the drainage of the internal mammary nodes into the subclavian vein. Moreover, Park and Tarver reported 3 cases of solitary sternal metastasis from breast carcinoma that was treated with systemic therapy . Although follow-up results on these patients were not clearly mentioned, the authors stated that single metastasis in the sternum have the unique tendency to remain solitary for longer than metastasis to other sites. According to McKenna et al., even given the advances in the treatment of locally recurrent and advanced breast cancer, 50% to 70% of patients will still succumb to their disease .
Mortality after chest wall resection is reported to be 1.6% to 4.5% . The choice of surgical technique depends on a number of factors, of which the most important is the size and site of the lesion.
There is a considerable discussion as to whether the missing bony thorax should be reconstructed . The decision not to reconstruct the skeleton depends on the size and location of the defect, the presence of wound infection, and whether or not the tumour had been previously irradiated. Generally, lesions less than 5 cm in size in any location and up to 10 cm in posterior size need not require functional reconstruction.
Various techniques have been used to repair the defects in the anterior thoracic wall, such as fascia lata, rib grafts, large skin flaps, the contralateral breast, myocutaneous flaps, and various types of prosthetic materials (polypropylene and Vicryl nets, Gore-Tex patches). The use of prosthesis has not been reported to increase septic complications or foreign body reactions . The numerous advances in chest wall reconstruction over the years, including the use of muscle transposition and musculocutaneous flaps, have made these techniques the mainstay in chest wall reconstruction . Gore-Tex has the advantage of being impermeable to air and liquids and provides excellent results in terms of stability, intrathoracic organ protection, and pulmonary expansion .
The most important task as a thoracic surgeon assessing a patient with a solitary metastatic carcinoma of the sternum is to determine the tumor's likelihood of recurrence after surgery and its amenability to a complete resection. The extensive literature on relapsed breast cancer demonstrates that patients with bone metastasis coincident with the initial presentation of their breast cancer have the best outlook, while histological grade and type are the next most important prognostic factors. Patients with grades I and II ductal or lobular cancers have better prognosis than those with grade III tumors. Estrogen receptor positivity, a long disease-free interval (>3 years versus <3 years) and a pre-menopausal status are other factors that predict a longer survival of patients. In the case of our patient, the recurrence after 9 years following mastectomy, chemotherapy and radiotherapy led us to treat the sternal metastasis aggressively.
The localization of the probable defect after resection, its depth, width, convenient tissue flaps, and the tissue amount necessary for reconstruction must be evaluated pre-operatively. The serratus anterior muscle is a reliable muscle flap with a consistently long pedicle and excellent malleability, thus permitting the coverage of complex three dimensional wounds. It has been successfully used for flap reconstruction of the lower limps, dorsal surface hand defects, injuries to the head, neck and extremities, as well as bony and soft tissue defects in the face. There are only a few cases of flap reconstruction in relation to anterior thoracic wall defects [18, 19].
Metastatic breast cancer confined to the skeletal system is a complication that can be diagnosed relatively easily. It is highly responsive to treatment and it is frequently associated with extended patient survival . As our experience in solid recurrent breast cancer sternal metastasis teaches, full thickness chest wall resection remains integral in controlling major complications associated with the chest wall reconstruction because it improves the quality of our patient's life, may provide patients with durable disease-free remission, and can improve survival with low mortality and morbidity results.
Written informed consent was obtained from our patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Mora EM, Singletary SE, Buzdar AU, Johnston DA: Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients. Ann Surg Oncol. 1996, 3: 162-168. 10.1007/BF02305796.View ArticlePubMedGoogle Scholar
- Kwai AH, Stomper PC, Kaplan WD: Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer. J Nucl Med. 1988, 29: 324-328.PubMedGoogle Scholar
- Batson OV: The vertebral system of veins as a means for cancer dissemination. Prog Clin Cancer. 1967, 3: 1-18.PubMedGoogle Scholar
- Takanami I, Ohnishi H: Study of surgical resection of sternal metastasis from carcinoma of the breast (Japanese). Gan No Rinsho. 1989, 35: 1735-1738.PubMedGoogle Scholar
- Gilliland MD, Barton RM, Copeland EM: The implications of local recurrence of breast cancer as the first sign of therapeutic failure. Ann Surg. 1983, 197: 284-287. 10.1097/00000658-198303000-00007.View ArticlePubMedPubMed CentralGoogle Scholar
- Muscolino G, Valente M, Leguaglie C, Ravasi G: The correlation between first disease-free interval from mastectomy to second disease-free interval from chest wall resection. Eur J Surg Oncol. 1992, 18: 49-52.PubMedGoogle Scholar
- Picciochi A, Granone P, Cardillo G, Margaritora S, Benzoni C, D'ugo D: Prosthetic reconstruction of the chest wall. Int Surg. 1993, 78: 221-224.Google Scholar
- Noguchi S, Miyauchi K, Nishizawa Y, Imaoka S, Koyama H, Iwanaga T: Results of surgical treatment for sternal metastasis of breast cancer. Cancer. 1988, 62: 1397-1401. 10.1002/1097-0142(19881001)62:7<1397::AID-CNCR2820620726>3.0.CO;2-2.View ArticlePubMedGoogle Scholar
- Lequaglie C, Massone PB, Giudice G, Conti B: Gold standard for sternectomies and plastic reconstructions after resections for primary or secondary sternal neoplasms. Ann Surg Oncol. 2002, 9: 472-479. 10.1245/aso.2002.9.5.472.View ArticlePubMedGoogle Scholar
- McCormack PM, Bains M, Burt ME, Martini N, Chagassian T, Hidaldo DA: Local recurrent mammary carcinoma failing multimodality therapy: a solution. Arch Surg. 1989, 124: 158-161.View ArticlePubMedGoogle Scholar
- Avital S, Cohen M, Skornik Y, Weiss J, Meller I, Shafir R: Solitary sternal breast cancer metastasis treated by sternectomy and muscle flap reconstruction. Eur J Surg. 2000, 166: 92-94. 10.1080/110241500750009799.View ArticlePubMedGoogle Scholar
- Brower ST, Weinberg H, Tartter PI, Camunes J: Chest wall resection for locally recurrent breast cancer: indications, techniques and results. J Surg Oncol. 1992, 49: 189-195. 10.1002/jso.2930490312.View ArticlePubMedGoogle Scholar
- Park HM, Tarver RD: Solitary sternal metastasis from breast carcinoma. Clin Nucl Med. 1983, 8: 373-374. 10.1097/00003072-198308000-00012.View ArticlePubMedGoogle Scholar
- McKenna RJ, McMurty MJ, Larson DL: A perspective on chest wall resection in patients with breast cancer. Am Thorac Surg. 1984, 38: 482-View ArticleGoogle Scholar
- Martini N, Huvos Ag, Burt ME, Heelan RT, Bains MS, McCormack PM, Rusch VW, Weber M, Downey RJ, Ginsberg RJ: Predictors of survival in malignant tumors of sternum. J Thorac Cardiovasc Surg. 1996, 111: 96-106. 10.1016/S0022-5223(96)70405-1.View ArticlePubMedGoogle Scholar
- Deschamps C, Tirnaksiz BM, Darbandi R, Trastek VF, Allen MS, Miller DL, Arnold PG, Pairolero PC: Early and long-term results of prosthetic chest wall reconstruction. J Thorac Cardiovasc Surg. 1999, 117: 588-592. 10.1016/S0022-5223(99)70339-9.View ArticlePubMedGoogle Scholar
- Arnold PG, Pairolero PC: Chest-wall reconstruction: an account of 500 consecutive patients. Plast Reconstr Surg. 1996, 98: 904-910.View ArticleGoogle Scholar
- Sakaguchi K, Horio H, Kuwabara K, Terao Y: Large chest wall reconstruction using a pedicle osteomuscle composite flap: report of a case. Surg Today. 2006, 36 (2): 180-183. 10.1007/s00595-005-3113-5.View ArticlePubMedGoogle Scholar
- Arnold PG, Pailero PC, Waldorf JC: The serratus anterior muscle: intrathoracic and extrathoracic utilization. Plast Reconstr Surg. 1984, 73: 240-246.View ArticlePubMedGoogle Scholar
- Sherry MM, Greco FA, Johnson DH, Hainsworth JD: Metastatic breast cancer confined to skeletal system: an indolent disease. Am J Med. 1986, 81: 381-386. 10.1016/0002-9343(86)90286-X.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.